Calcium-insensitive splice variants of mammalian E1 subunit of 2-oxoglutarate dehydrogenase complex with tissue-specific patterns of expression
doi: 10.1002/adfm.201909035
Biochemistry 35, 32973308
If Youre Asking This Question, Youre Not Alone Over the past two years, one question has come up in nearly every employee benefits renewal meeting: Should our health plan cover GLP-1 medications? Medications such as Wegovy, Zepbound, Ozempic, and Mounjaro have transformed the treatment of obesity and diabetes
To schedule an appointment please contact us or simply request an appointment online
That changed in November 2025, when Novo and Lilly announced an agreement with the White House to significantly drop prices for self-pay patients and extension of Medicare coverage for weight loss starting April 2026